Tsumura Yoshinori, Tsushima Yu, Tamura Azusa, Hasebe Makiko, Kobayashi Tsunefumi
Pharmaceutical Development Coordination Department, Teijin Pharma Limited.
Pharmacology Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited.
Anal Sci. 2019 Apr 10;35(4):455-460. doi: 10.2116/analsci.18P427. Epub 2019 Jan 11.
A novel ex vivo method to simultaneously evaluate hepatic glucose utilization, uptake, and production was developed in rats. The right lateral lobe of the liver was perfused with Krebs-Henseleit bicarbonate buffer containing 5 mmol/L uniformly labeled C-glucose ([U-C]-glucose). The whole glucose concentration in the perfusate was measured by colorimetric assay, and the concentrations of [U-C]-glucose (natural isotope) or [U-C]-glucose were estimated on the basis of the abundance ratio of [U-C]-glucose or [U-C]-glucose, which were measured by GC-MS. The difference in whole glucose and [U-C]-glucose concentrations between the baseline and effluent perfusate represents hepatic glucose utilization and glucose uptake, respectively. The [U-C]-glucose concentration in the effluent perfusate corresponds to hepatic glucose production. With this method, we clarified the precise mechanism that underlies the hepatic impairment of diabetic animals and pharmacological effects of anti-diabetic agents. Thus, this method is useful for the pathophysiological and pharmacological research of type 2 diabetes.
在大鼠中开发了一种同时评估肝脏葡萄糖利用、摄取和生成的新型离体方法。用含有5 mmol/L均匀标记的C葡萄糖([U-C]-葡萄糖)的Krebs-Henseleit碳酸氢盐缓冲液灌注肝脏的右外侧叶。通过比色法测定灌注液中的总葡萄糖浓度,并根据通过气相色谱-质谱法测量的[U-C]-葡萄糖或[U-C]-葡萄糖的丰度比估算[U-C]-葡萄糖(天然同位素)或[U-C]-葡萄糖的浓度。基线灌注液和流出灌注液之间总葡萄糖和[U-C]-葡萄糖浓度的差异分别代表肝脏葡萄糖利用和葡萄糖摄取。流出灌注液中的[U-C]-葡萄糖浓度对应于肝脏葡萄糖生成。通过这种方法,我们阐明了糖尿病动物肝脏损伤的精确机制以及抗糖尿病药物的药理作用。因此,该方法对于2型糖尿病的病理生理学和药理学研究很有用。